Takeda Pharmaceutical TAK
NYSE TAK
$20.08 +0.47 (+2.37%)
As of: Oct 20, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Total Debt (2017 - 2026)

Updated

Takeda Pharmaceutical's Total Debt was $690.85 million in the quarter ended Jun 30, 2026, down 51.3% from $1.42 billion a year earlier and down 97.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Total Debt (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Total Debt at Takeda Pharmaceutical came in at $29.97 billion, up 9.1% from the prior year.

  • Total Debt shows a five-year compound annual growth rate of -8.2% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Total Debt was $27.48 billion in the year ended Mar 31, 2025 (-14.2%), $32.04 billion in the year ended Mar 31, 2024 (+2.4%), $31.3 billion in the year ended Mar 31, 2023 (-19.0%) and $38.63 billion in the year ended Mar 31, 2022 (-15.8%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Debt since the quarter ended Nov 29, 2019.
  • Compared with a year earlier, Total Debt was higher in three of the last eight quarters, with an average decline of 11.2%.
  • The best year-over-year quarter for Total Debt over five years was the quarter ended Sep 30, 2023 (growth of 160.1%); the worst was the quarter ended Jun 30, 2026 (a decline of 51.3%).
  • Per Business Quant data, TAK's Total Debt in the three quarters before the quarter ended Jun 30, 2026 was $28.76 billion (quarter ended Mar 31, 2026), $1.76 billion (quarter ended Dec 31, 2025) and $1.53 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 49.04 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 70.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 63.19 Bn
10 Takeda Pharmaceutical 63.21 Bn 39.57 Bn 5.10 Bn 30.98 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.98 Bn
Mar 31, 2026 31.43 Bn
Dec 31, 2025 30.94 Bn
Sep 30, 2025 32.96 Bn
Jun 30, 2025 32.31 Bn
Mar 31, 2025 31.64 Bn
Dec 31, 2024 33.73 Bn
Sep 30, 2024 34.92 Bn
Jun 30, 2024 35.22 Bn
Mar 31, 2024 32.93 Bn
Dec 31, 2023 34.19 Bn
Sep 30, 2023 33.34 Bn
Jun 30, 2023 33.33 Bn
Mar 31, 2023 34.29 Bn
Dec 31, 2022 33.24 Bn
Sep 30, 2022 32.66 Bn
Jun 30, 2022 35.36 Bn
Mar 31, 2022 37.22 Bn
Dec 31, 2021 40.79 Bn
Jun 30, 2021 44.13 Bn
API Access

Takeda Pharmaceutical Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=TAK&period=max&api_key=YOUR_API_KEY